AlphaCore Capital’s Bio-Techne TECH Stock Holding History

AlphaCore Capital’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$581K	Buy	8,223 +3,147	+62%	+$170K	0.01%	622
2026 Q1	$265K	Buy	+5,076	New	+$305K	0.01%	739

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AlphaCore Capital's TECH Position: Q2 2026 in Review

AlphaCore Capital increased its Bio-Techne (TECH) stake by 62% in Q2 2026, buying an estimated $170K and bringing the position to 8,223 shares worth $581K. The position accounts for 0.01% of the portfolio, ranked #622.

AlphaCore Capital first reported a position in TECH in Q1 2026 and has held it in 2 quarters since. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

AlphaCore Capital held 8,223 shares of Bio-Techne worth $581K as of Q2 2026.
AlphaCore Capital bought 3,147 Bio-Techne shares in Q2 2026, an estimated $170K.
Bio-Techne made up 0.01% of AlphaCore Capital's portfolio in Q2 2026, its #622 holding.
AlphaCore Capital first reported a position in Bio-Techne in Q1 2026 and has held it in 2 quarters since.
593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.